The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease

O Yanartas,1 HT Kani,2 E Bicakci,3 I Kilic,4 M Banzragch,3 C Acikel,5 O Atug,3 K Kuscu,1 N Imeryuz,3 H Akin31Department of Psychiatry, 2Department of Internal Medicine, 3Department of Gastroenterology, 4Department of Internal Medicine, Marmara University School of Medicine, Istanbul, 5Department of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yanartas O, Kani HT, Bicakci E, Kilic I, Banzragch M, Acikel C, Atug O, Kuscu K, Imeryuz N, Akin H
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Anxiety Depression Sexual Dysfunction Psychiatric Treatment Inflammatory Bowel Disease. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/bb192f4a27654a2eb89e9cb69a506234
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bb192f4a27654a2eb89e9cb69a506234
record_format	dspace
spelling	oai:doaj.org-article:bb192f4a27654a2eb89e9cb69a5062342021-12-02T04:56:18ZThe effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease1178-2021https://doaj.org/article/bb192f4a27654a2eb89e9cb69a5062342016-03-01T00:00:00Zhttps://www.dovepress.com/the-effects-of-psychiatric-treatment-on-depression-anxiety-quality-of--peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021O Yanartas,1 HT Kani,2 E Bicakci,3 I Kilic,4 M Banzragch,3 C Acikel,5 O Atug,3 K Kuscu,1 N Imeryuz,3 H Akin31Department of Psychiatry, 2Department of Internal Medicine, 3Department of Gastroenterology, 4Department of Internal Medicine, Marmara University School of Medicine, Istanbul, 5Department of Public Health, Gulhane Military Medical Academy, Ankara, TurkeyObjective: Depression and anxiety are common disorders in inflammatory bowel disease (IBD). Our aim is to prospectively determine the effect of psychiatric treatment on scores for depression, anxiety, quality of life (QoL), and sexual dysfunction in an outpatient population diagnosed with IBD and also anxiety and/or depression disorder.Patients and methods: Patients who scored higher than the cutoff point on the Hospital Anxiety Depression Scale were referred for further structured psychiatric evaluation and determination of the need for psychiatric drug treatment. Patients who underwent drug therapy completed Short Form-36 (SF-36) and the Arizona Sexual Experience Scale at baseline and after 6 months of follow-up.Results: Major depressive disorder and generalized anxiety disorder were the most common diagnoses. After 6 months, 47 patients had completely adhered to drug treatment (group A), whereas 20 were nonadherent (group B). In group A, all domains of SF-36, Arizona Sexual Experience Scale, depression/anxiety scores, and Crohn’s disease activity index were statistically improved after treatment when compared with the baseline. In group B, the three domains of SF-36, platelet count, and mean corpuscular volume were worse between baseline and at 6 months.Conclusion: In IBD patients having any psychiatric disorder, 6 months of antidepressant drug treatment is associated with an improvement in depression, anxiety, QoL, and sexual functioning scores, as well as an improvement in Crohn’s disease activity index. On the other hand, insufficient psychiatric treatment seems to be related to a poor QoL.Keywords: anxiety, depression, sexual dysfunction, psychiatric treatment, inflammatory bowel diseaseYanartas OKani HTBicakci EKilic IBanzragch MAcikel CAtug OKuscu KImeryuz NAkin HDove Medical PressarticleAnxietyDepressionSexual DysfunctionPsychiatric TreatmentInflammatory Bowel Disease.Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 673-683 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	Anxiety Depression Sexual Dysfunction Psychiatric Treatment Inflammatory Bowel Disease. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Anxiety Depression Sexual Dysfunction Psychiatric Treatment Inflammatory Bowel Disease. Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Yanartas O Kani HT Bicakci E Kilic I Banzragch M Acikel C Atug O Kuscu K Imeryuz N Akin H The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
description	O Yanartas,1 HT Kani,2 E Bicakci,3 I Kilic,4 M Banzragch,3 C Acikel,5 O Atug,3 K Kuscu,1 N Imeryuz,3 H Akin31Department of Psychiatry, 2Department of Internal Medicine, 3Department of Gastroenterology, 4Department of Internal Medicine, Marmara University School of Medicine, Istanbul, 5Department of Public Health, Gulhane Military Medical Academy, Ankara, TurkeyObjective: Depression and anxiety are common disorders in inflammatory bowel disease (IBD). Our aim is to prospectively determine the effect of psychiatric treatment on scores for depression, anxiety, quality of life (QoL), and sexual dysfunction in an outpatient population diagnosed with IBD and also anxiety and/or depression disorder.Patients and methods: Patients who scored higher than the cutoff point on the Hospital Anxiety Depression Scale were referred for further structured psychiatric evaluation and determination of the need for psychiatric drug treatment. Patients who underwent drug therapy completed Short Form-36 (SF-36) and the Arizona Sexual Experience Scale at baseline and after 6 months of follow-up.Results: Major depressive disorder and generalized anxiety disorder were the most common diagnoses. After 6 months, 47 patients had completely adhered to drug treatment (group A), whereas 20 were nonadherent (group B). In group A, all domains of SF-36, Arizona Sexual Experience Scale, depression/anxiety scores, and Crohn’s disease activity index were statistically improved after treatment when compared with the baseline. In group B, the three domains of SF-36, platelet count, and mean corpuscular volume were worse between baseline and at 6 months.Conclusion: In IBD patients having any psychiatric disorder, 6 months of antidepressant drug treatment is associated with an improvement in depression, anxiety, QoL, and sexual functioning scores, as well as an improvement in Crohn’s disease activity index. On the other hand, insufficient psychiatric treatment seems to be related to a poor QoL.Keywords: anxiety, depression, sexual dysfunction, psychiatric treatment, inflammatory bowel disease
format	article
author	Yanartas O Kani HT Bicakci E Kilic I Banzragch M Acikel C Atug O Kuscu K Imeryuz N Akin H
author_facet	Yanartas O Kani HT Bicakci E Kilic I Banzragch M Acikel C Atug O Kuscu K Imeryuz N Akin H
author_sort	Yanartas O
title	The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
title_short	The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
title_full	The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
title_fullStr	The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
title_full_unstemmed	The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
title_sort	effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/bb192f4a27654a2eb89e9cb69a506234
work_keys_str_mv	AT yanartaso theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT kaniht theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT bicakcie theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT kilici theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT banzragchm theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT acikelc theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT atugo theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT kuscuk theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT imeryuzn theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT akinh theeffectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT yanartaso effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT kaniht effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT bicakcie effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT kilici effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT banzragchm effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT acikelc effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT atugo effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT kuscuk effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT imeryuzn effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease AT akinh effectsofpsychiatrictreatmentondepressionanxietyqualityoflifeandsexualdysfunctioninpatientswithinflammatoryboweldisease
_version_	1718400975802204160

The effects of psychiatric treatment on depression, anxiety, quality of life, and sexual dysfunction in patients with inflammatory bowel disease

Ejemplares similares